Science Explorer Back to mapMap
Discussion
Company · Maastricht · Netherlands

PathoFinder (Netherlands)

pathofinder.comROR OpenAlex
Research works
27
▲ 68% vs 2018-21
Citations
433
15.9 per fractional work
Top-10% rate
10.3%
all institutions 10.0%
Open access
52%
world 40%
International
33%
world 18%
PathoFinder (Netherlands)

Not ranked overall: PathoFinder (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does PathoFinder (Netherlands) work in?

In all years, 69% of research at PathoFinder (Netherlands) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (68%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (5%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 19 fractional works · 68.6% of its workMedicine: 18 fractional works · 67.7% of its workOncology: 3 fractional works · 11.2% of its workEpidemiology: 3 fractional works · 9.5% of its workSurgery: 2 fractional works · 9.2% of its workPulmonary and Respiratory Medicine: 2 fractional works · 9.1% of its workInfectious Diseases: 1 fractional works · 4.7% of its workPathology and Forensic Medicine: 1 fractional works · 3.4% of its workObstetrics and Gynecology: 1 fractional works · 3.1% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.7% of its workRheumatology: 1 fractional works · 2.3% of its workReproductive Medicine: 0 fractional works · 1.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.4% of its workPhysiology: 0 fractional works · 1.1% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.0% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.0% of its workGastroenterology: 0 fractional works · 0.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.8% of its workNephrology: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.6% of its workTransplantation: 0 fractional works · 0.6% of its workHepatology: 0 fractional works · 0.6% of its workEmergency Medicine: 0 fractional works · 0.4% of its workDermatology: 0 fractional works · 0.3% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.3% of its workMicrobiology: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.4% of its workPeriodontics: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.3% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.2% of its workLife Sciences: 7 fractional works · 24.6% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 18.3% of its workMolecular Biology: 3 fractional works · 10.8% of its workCancer Research: 1 fractional works · 4.3% of its workGenetics: 1 fractional works · 2.2% of its workCell Biology: 0 fractional works · 0.3% of its workMolecular Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workImmunology and Microbiology: 1 fractional works · 4.7% of its workImmunology: 1 fractional works · 2.9% of its workMicrobiology: 0 fractional works · 1.3% of its workVirology: 0 fractional works · 0.3% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.6% of its workAgronomy and Crop Science: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.7% of its workPhysical Sciences: 2 fractional works · 6.7% of its workChemistry: 1 fractional works · 3.7% of its workSpectroscopy: 1 fractional works · 3.7% of its workEngineering: 1 fractional works · 2.0% of its workBiomedical Engineering: 1 fractional works · 2.0% of its workComputer Science: 0 fractional works · 0.8% of its workArtificial Intelligence: 0 fractional works · 0.8% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.1% of its workALL ITS WORKPathoFinder(Netherlands)27fractional works, all years
Life Sciences25%Physical Sciences7%Health Sciences69%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine1867.7%
    2. Dentistry00.4%
    3. Health Professions00.3%
    4. Nursing00.2%
    1. Biochemistry, Genetics and Molecular Biology518.3%
    2. Immunology and Microbiology14.7%
    3. Agricultural and Biological Sciences00.8%
    4. Neuroscience00.7%
    1. Chemistry13.7%
    2. Engineering12.0%
    3. Computer Science00.8%
    4. Physics and Astronomy00.2%
    1. Social Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.37× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 5.08× its world share, 0 worksImmunology and Micro…Computer Science: 0.15× its world share, 0 worksComputer ScienceEngineering: 0.11× its world share, 0 worksEngineeringPhysics and Astronomy: 0.25× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.11× its world share, 0 worksHealth ProfessionsMedicine: 3.26× its world share, 5 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.4×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology5.37×2 works
  2. Immunology and Microbiology5.08×0 works
  3. Medicine3.26×5 works
  4. Physics and Astronomy0.25×0 works
  5. Computer Science0.15×0 works
  6. Engineering0.11×0 works
  7. Health Professions0.11×0 works

Who are the top researchers at PathoFinder (Netherlands)?

Ranked on the quality score, Guus Simons and Martin Reijans lead among researchers whose main affiliation is PathoFinder (Netherlands).

  1. 1 Guus Simons Netherlands · #595,048 worldwide 4.2k citations · 45 works
  2. 2 Martin Reijans Netherlands · #1,813,009 worldwide 14k citations · 27 works
All ranked researchers at PathoFinder (Netherlands)

What are the most cited papers from PathoFinder (Netherlands)?

The most cited paper from PathoFinder (Netherlands) is "Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels" (Lieke Hol, Janneke A. Wilschut, Marjolein van Ballegooijen et al., 2009), with 273 citations. Next come "Predictors for Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Cohort Study" (172) and "LabDisk with complete reagent prestorage for sample-to-answer nucleic acid based detection of respiratory pathogens verified with influenza A H3N2 virus" (136).

Most cited papers
#PaperReleasedCitations
1 Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels Lieke Hol, Janneke A. Wilschut, Marjolein van Ballegooijen et al. · British Journal of Cancer Open access 31 Mar 2009 273
2 Predictors for Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Cohort Study Marjolein Sikkema et al. · The American Journal of Gastroenterology 17 May 2011 172
3 LabDisk with complete reagent prestorage for sample-to-answer nucleic acid based detection of respiratory pathogens verified with influenza A H3N2 virus Fabian Stumpf, Frank Schwemmer, Tobias Hutzenlaub et al. · Lab on a Chip Open access 26 Nov 2015 136
4 RespiFinder: a New Multiparameter Test To Differentially Identify Fifteen Respiratory Viruses Martin Reijans, Gijs Dingemans, Corné H. W. Klaassen et al. · Journal of Clinical Microbiology Open access 7 Feb 2008 131
5 Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years Celine H. Leenen, Margot G F van Lier, Helena C. van Doorn et al. · Gynecologic Oncology Feb 2012 120
All 59 most cited papers, with filters and sorting

Which keywords describe research at PathoFinder (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Survival Analysis, Clinical Practice Guidelines, Data Analysis, Cervical Cancer, Gene Expression and Neoadjuvant Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Epidemiology5▲ 5.0×29 topics
  2. Chemotherapy2▲ 12×13 topics
  3. Clinical Practice Guidelines2▲ 15×9 topics
  4. Survival Analysis2▲ 32×6 topics
  5. Cervical Cancer2▲ 73×2 topics
  6. Data Analysis2▲ 22×2 topics
  7. Diagnosis2▲ 6.3×16 topics
  8. Gene Expression2▲ 10×4 topics
  9. Global Burden2▲ 11×4 topics
  10. Human Papillomavirus2▲ 46×3 topics
  11. Neoadjuvant Therapy2▲ 27×5 topics
  12. Immunotherapy2▲ 8.5×9 topics
  13. Breast Cancer1▲ 19×6 topics
  14. Cancer Incidence1▲ 37×2 topics
  15. Cytology Screening1▲ 101×1 topic
  16. HPV Vaccination1▲ 101×1 topic
  17. Biomarkers1▲ 7.7×3 topics
  18. Precision Medicine1▲ 15×4 topics
  19. Genomics1▲ 12×3 topics
  20. Molecular Characterization1▲ 21×4 topics
  21. Treatment1▲ 3.0×11 topics
  22. Chiral Separation1▲ 30×1 topic
  23. Inflammation1▲ 1.57×10 topics
  24. Liquid Chromatography1▲ 25×1 topic
  25. Management1▲ 4.9×8 topics
  26. Mass Spectrometry1▲ 17×1 topic
  27. Metabolomics1▲ 69×1 topic
  28. Quantitative1▲ 31×2 topics
  29. Radiotherapy1▲ 10.0×5 topics
  30. Risk Factors1▲ 3.7×9 topics

Which research topics does PathoFinder (Netherlands) publish most on?

By volume in 2022-now: Metabolomics and Mass Spectrometry Studies, HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics and Estrogen and related hormone effects.

Metabolomics and Mass Sp…1Metabolomics and Mass Spectrometry Studies: 1 fractional worksHER2/EGFR in Cancer Rese…0HER2/EGFR in Cancer Research: 0 fractional worksCancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksEstrogen and related hormone effects: 0 fractional worksCytokine Signaling Pathways and Interactions: 0 fractional worksEsophageal Cancer Resear…0Esophageal Cancer Research and Treatment: 0 fractional worksOrthopaedic implants and arthroplasty: 0 fractional worksBreast Cancer Treatment Studies: 0 fractional worksColorectal Cancer Screening and Detection: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional works
Molecular BiologyOncologyCancer ResearchGenetics1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Metabolomics and Mass Spectrometry Studies Molecular Biology 1 works
  2. 2 HER2/EGFR in Cancer Research Oncology 0 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 0 works
  4. 4 Estrogen and related hormone effects Genetics 0 works
  5. 5 Cytokine Signaling Pathways and Interactions Oncology 0 works
  6. 6 Esophageal Cancer Research and Treatment Surgery 0 works
  7. 7 Orthopaedic implants and arthroplasty Surgery 0 works
  8. 8 Breast Cancer Treatment Studies Cancer Research 0 works
  9. 9 Colorectal Cancer Screening and Detection Oncology 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.0%not open48.0%

World: 40% of research is openly available.

with international co-authors33.0%domestic only67.0%

World: 18% is written across borders.

How has PathoFinder (Netherlands)'s research output changed?

Output in 2022-2025 was 68% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PathoFinder (Netherlands) as a percentage of every work published that year, 0.0000100% in 2024.

still counting0.00020%0.00040%PathoFinder (Netherlands)0.000079% in 202519801990200020102020

Fractional works of PathoFinder (Netherlands) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Maastricht

All research institutions in Maastricht

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PathoFinder (Netherlands). Posts are plain text and can be reported.